JP5592360B2 - イミダゾピリミジノンおよびその使用 - Google Patents

イミダゾピリミジノンおよびその使用 Download PDF

Info

Publication number
JP5592360B2
JP5592360B2 JP2011515027A JP2011515027A JP5592360B2 JP 5592360 B2 JP5592360 B2 JP 5592360B2 JP 2011515027 A JP2011515027 A JP 2011515027A JP 2011515027 A JP2011515027 A JP 2011515027A JP 5592360 B2 JP5592360 B2 JP 5592360B2
Authority
JP
Japan
Prior art keywords
alkyl
alkylene
group
product
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2011515027A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011526247A5 (enExample
JP2011526247A (ja
Inventor
ジョン・ジョセフ・デッドマン
エリック・デイル・ジョーンズ
ジャン・ターン・レ
デイビッド・イアン・ローズ
ネーラナト・ティエントン
ニコラス・アンドリュー・バン・デ・グラフ
リサ・ジェーン・ウィンフィールド
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tali Digital Ltd
Original Assignee
Avexa Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2008903406A external-priority patent/AU2008903406A0/en
Application filed by Avexa Ltd filed Critical Avexa Ltd
Publication of JP2011526247A publication Critical patent/JP2011526247A/ja
Publication of JP2011526247A5 publication Critical patent/JP2011526247A5/ja
Application granted granted Critical
Publication of JP5592360B2 publication Critical patent/JP5592360B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2011515027A 2008-07-02 2009-07-02 イミダゾピリミジノンおよびその使用 Expired - Fee Related JP5592360B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2008903406 2008-07-02
AU2008903406A AU2008903406A0 (en) 2008-07-02 Imidazopyrimidinones and uses thereof
US16193109P 2009-03-20 2009-03-20
US61/161,931 2009-03-20
PCT/AU2009/000857 WO2010000031A1 (en) 2008-07-02 2009-07-02 Imidazopyrimidinones and uses thereof

Publications (3)

Publication Number Publication Date
JP2011526247A JP2011526247A (ja) 2011-10-06
JP2011526247A5 JP2011526247A5 (enExample) 2012-03-29
JP5592360B2 true JP5592360B2 (ja) 2014-09-17

Family

ID=41465416

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011515027A Expired - Fee Related JP5592360B2 (ja) 2008-07-02 2009-07-02 イミダゾピリミジノンおよびその使用

Country Status (5)

Country Link
US (1) US8431581B2 (enExample)
EP (1) EP2291377B1 (enExample)
JP (1) JP5592360B2 (enExample)
CA (1) CA2729656A1 (enExample)
WO (1) WO2010000031A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2729649A1 (en) * 2008-07-02 2010-01-07 Avexa Limited Thiazopyrimidinones and uses thereof
PL2212324T3 (pl) 2008-07-02 2014-11-28 Avexa Ltd Związki posiadające właściwości przeciwwirusowe
AR080314A1 (es) 2010-02-26 2012-03-28 Japan Tobacco Inc Derivado de 1,3,4,8-tetrahidro-2h-pirido (1,2-a) pirazina y su uso como inhibidor de la hiv integrasa
US11042897B2 (en) 2010-08-30 2021-06-22 Adap.Tv, Inc. System and method for determining effects of multi-channel media sources on multi-channel conversion events
US20160002247A1 (en) * 2013-03-01 2016-01-07 The University Of Tokyo 8-substituted imidazopyrimidinone derivative having autotaxin inhibitory activity
BR112015028173A2 (pt) 2013-05-10 2017-07-25 Nimbus Apollo Inc inibidores de acc e usos dos mesmos
EP2994138A4 (en) * 2013-05-10 2016-12-28 Nimbus Apollo Inc ACC-HEMMER AND USES THEREOF
EP2994139B1 (en) 2013-05-10 2019-04-10 Gilead Apollo, LLC Acc inhibitors and uses thereof
JP6417403B2 (ja) 2013-05-10 2018-11-07 ギリアド アポロ, エルエルシー Acc阻害剤及びその使用
WO2015064714A1 (ja) * 2013-10-31 2015-05-07 国立大学法人東京大学 オートタキシン阻害活性を有する1-置換イミダゾピリミジノン誘導体
MX2022006700A (es) 2019-12-02 2022-09-02 Storm Therapeutics Ltd Compuestos poliheterociclicos como inhibidores de mettl3.
CN116199605A (zh) * 2023-02-27 2023-06-02 上海睿腾医药科技有限公司 一种5-氯-2-羟基-二甲基苯磺酰胺的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE15187654T1 (de) 2001-08-10 2016-12-01 Shionogi & Co., Ltd Antivirales Mittel
US7273859B2 (en) * 2004-05-12 2007-09-25 Bristol-Myers Squibb Company HIV integrase inhibitors: cyclic pyrimidinone compounds
EP1866313A1 (en) * 2005-03-31 2007-12-19 Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. Hiv integrase inhibitors
KR20100049698A (ko) * 2006-12-22 2010-05-12 아벡사 리미티드 바이사이클 피리미디논 및 그 용도

Also Published As

Publication number Publication date
CA2729656A1 (en) 2010-01-07
US8431581B2 (en) 2013-04-30
EP2291377A4 (en) 2011-10-05
JP2011526247A (ja) 2011-10-06
US20110028487A1 (en) 2011-02-03
WO2010000031A1 (en) 2010-01-07
EP2291377A1 (en) 2011-03-09
EP2291377B1 (en) 2015-02-18

Similar Documents

Publication Publication Date Title
JP5592360B2 (ja) イミダゾピリミジノンおよびその使用
JP5535204B2 (ja) 抗ウイルス特性を有する化合物
EP2247601B1 (en) Thiazopyrimidinones and uses thereof
JP5208962B2 (ja) 二環式ピリミジノンおよびその使用
JP2022511819A (ja) ヘテロアリールジヒドロピリミジン誘導体及びb型肝炎感染症を治療する方法
JP2022513297A (ja) ヘテロアリールジヒドロピリミジン誘導体及びb型肝炎感染を治療する方法
TWI617553B (zh) 吖丁啶基氧苯基吡咯啶化合物
CN103080113A (zh) 7,9-氮基-4-氧代-4h-吡啶并[l,2-a]嘧啶-2-羧酸苄基酰胺抗病毒剂
WO2022169882A1 (en) Methods and treatment of viral infection caused by sars-cov-2
HK1160645A (en) Compounds having antiviral properties
JPWO1999043678A1 (ja) パーキンソン病の治療・予防剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120203

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120203

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130910

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20131209

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20131216

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140109

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140212

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140509

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140516

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140611

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140715

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140731

R150 Certificate of patent or registration of utility model

Ref document number: 5592360

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees